Clinical Trials Browser

Phase 2 × gemcitabine-oxaliplatin regimen × Lymphoid × Clear all

NCT04948788 2021-09-28

SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma

Phase 2 Unknown

Recurrence, Lymphoma, B-Cell

NCT00169195 2015-09-02

Rituximab, Gemcitabine and Oxaliplatin (R-GEMOX) for Refractory/Relapsed B-cell Lymphoma

Phase 2 Completed

Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse